HDAC3 drives type II alveolar epithelial barrier dysfunction via MKP1 deacetylation in radiation‐induced lung injury
4 affiliations
- 1Department of Oncology Renmin Hospital of Wuhan University Wuhan China
- 2Central Laboratory Renmin Hospital of Wuhan University Wuhan China
- 3Key Laboratory of Hubei Province for Digestive System Disease Renmin Hospital of Wuhan University Wuhan China
- 4Department of Thoracic Surgery Renmin Hospital of Wuhan University Wuhan China
Abstract
Histone deacetylase 3 (HDAC3) is a key biological macromolecule involved in protein acetylation and inflammatory signalling. Although its biological functions are well recognised, the molecular mechanisms through which HDAC3 regulates stress‐induced responses of alveolar epithelial cells during early‐stage radiation‐induced lung injury (RILI) remain incompletely understood. In this study, using AT2‐specific HDAC3 conditional knockout mice as well as primary mouse AT2 and A549 cell models, we found that radiation markedly upregulates HDAC3 expression, whereas HDAC3 knockdown alleviates radiation‐induced disruption of the alveolar epithelial barrier. Transcriptomic analysis further revealed that HDAC3 influences barrier integrity by modulating MAPK‐mediated inflammation and apoptosis. Pharmacological intervention with the selective HDAC3 inhibitor RGFP966 also demonstrated that HDAC3 inhibition mitigates radiation‐induced oxidative stress imbalance. Mechanistically, HDAC3 deacetylates MKP1, enhancing p38 mitogen‐activated protein kinase (p38 MAPK) phosphorylation, promoting FBJ murine osteosarcoma viral oncogene homolog (c‐Fos) expression, and activating activator protein‐1 (AP‐1), thereby driving downstream inflammatory signalling. Collectively, our findings support a role for the HDAC3–MKP1–p38 MAPK–c‐Fos/AP‐1 axis in regulating inflammatory responses in AT2 cells and highlight HDAC3 as a potential molecular target for mitigating alveolar epithelial injury in early‐stage RILI.
Related
- Epithelial Fucosylation Drives Airway Barrier Dysfunction and Allergic Inflammation via a FUT1 -CDH12 Axis
- Anti-Nectin4 monoclonal antibodies attenuate airway inflammation and epithelial barrier dysfunction in asthma
- A spatiotemporal atlas of radiation-induced brain injury reveals dysfunction of the blood-CSF barrier
- The mucosal immune microenvironment in chronic pharyngitis: epithelial barrier dysfunction, inflammatory persistence, and therapeutic perspectives
- Malus domestica fruit-derived vesicles extract protect against upstream cellular hallmarks of vascular inflammation and epithelial barrier dysfunction
BibTeX
@article{li2026hdac3,
title = {{HDAC3 drives type II alveolar epithelial barrier dysfunction via MKP1 deacetylation in radiation‐induced lung injury}},
author = {Boyang Li and Ning Li and Rui Xiong and Yifan Zuo and Yi Liu and Guoqing Luo and Wenjun Zhang and Zhuya Xiao and Long Wu and Min Peng},
journal = {Clinical and Translational Medicine},
year = {2026},
month = nov,
doi = {10.1002/ctm2.70877},
url = {https://doi.org/10.1002/ctm2.70877},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - HDAC3 drives type II alveolar epithelial barrier dysfunction via MKP1 deacetylation in radiation‐induced lung injury
AU - Boyang Li
AU - Ning Li
AU - Rui Xiong
AU - Yifan Zuo
AU - Yi Liu
AU - Guoqing Luo
AU - Wenjun Zhang
AU - Zhuya Xiao
AU - Long Wu
AU - Min Peng
PY - 2026
DA - 2026/11/09
JO - Clinical and Translational Medicine
DO - 10.1002/ctm2.70877
UR - https://doi.org/10.1002/ctm2.70877
AB - Histone deacetylase 3 (HDAC3) is a key biological macromolecule involved in protein acetylation and inflammatory signalling. Although its biological functions are well recognised, the molecular mechanisms through which HDAC3 regulates stress‐induced responses of alveolar epithelial cells during early‐stage radiation‐induced lung injury (RILI) remain incompletely understood. In this study, using AT2‐specific HDAC3 conditional knockout mice as well as primary mouse AT2 and A549 cell models, we found that radiation markedly upregulates HDAC3 expression, whereas HDAC3 knockdown alleviates radiation‐induced disruption of the alveolar epithelial barrier. Transcriptomic analysis further revealed that HDAC3 influences barrier integrity by modulating MAPK‐mediated inflammation and apoptosis. Pharmacological intervention with the selective HDAC3 inhibitor RGFP966 also demonstrated that HDAC3 inhibition mitigates radiation‐induced oxidative stress imbalance. Mechanistically, HDAC3 deacetylates MKP1, enhancing p38 mitogen‐activated protein kinase (p38 MAPK) phosphorylation, promoting FBJ murine osteosarcoma viral oncogene homolog (c‐Fos) expression, and activating activator protein‐1 (AP‐1), thereby driving downstream inflammatory signalling. Collectively, our findings support a role for the HDAC3–MKP1–p38 MAPK–c‐Fos/AP‐1 axis in regulating inflammatory responses in AT2 cells and highlight HDAC3 as a potential molecular target for mitigating alveolar epithelial injury in early‐stage RILI.
SN - 2001-1326
ER -